Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies

US Patent 10017576 · Granted Jul 10, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lysosomal enzymes modified by cell based glycoengineering2025
CORE3-MUC1 binding polypeptides and uses thereof2024
CORE3-MUC1 binding polypeptides and uses thereof2024
Modified recombinant lysosomal alpha-galactosidase A and aspartylglucoaminidase 2023
Tn-MUC4 binding polypeptides and uses thereof2021
Tn-MUC4 binding polypeptides and uses thereof2021
Generation of a cancer-specific immune response toward MUC1 and cancer specific 2021
Generation of a cancer-specific immune response toward MUC1 and cancer specific 2021
Generation of a cancer-specific immune response toward MUC1 and cancer specific 2021
Generation of a cancer-specific immune response toward MUC1 and cancer specific 2021
Generation of a cancer-specific immune response toward MUC1 and cancer specific 2021
Generation of a cancer-specific immune response toward MUC1 and cancer specific 2021